| Followers | 10 |
| Posts | 605 |
| Boards Moderated | 0 |
| Alias Born | 06/30/2014 |
Tuesday, November 26, 2019 5:19:41 PM
Breaks above $30, again... finally
My morning e mail:
I still recommend RLMD here but certainly if it ever drops below 25. It seems to sell off in the mornings then strengthens in early afternoon, seems to be trying to get back above $30 now.
I don’t know of any developments lately, positive or negative, I assume the first buy recommendation is being written about it by one of 3 brokerage firms that know about RLMD. Nobody else seems to know about it still.
Another positive event would be having the FDA designate their drug REL-1017 a ‘breakthrough therapy’ they are already on the FDA list of Fast Track approval candidates, back in 2017, ‘Breakthrough’ designation brings additional support from the FDA.
I think in a year it will be over $100/ share and much higher in 3 years if it isn’t acquired. To their credit there are no huge egos involved, they want to bring this drug to market as soon as possible, they don’t seem to be interested in building a corporate monument.
This is the announcement that drove the stock from 11 to 36 in one day, cooled off after that but seems to be climbing back up:
https://www.relmada.com/news-events/press-releases/detail/200/relmada-therapeutics-announces-top-line-results-from
I post my ramblings on this message board “IHUB” under the name ‘VictorMasonIsRight’ ( my nick name at Lehman Brothers, they didn’t think my name was cool enough):
https://investorshub.advfn.com/Relmada-Therapeutics-Inc-RLMD-28735/
The company does not leak inside information so everything I say is my own opinion. Feel free to send this to any trusted advisor or friend. I will send you more info soon. I also write about it on twitter as ‘@XXXXXXXXXXX68’
Padre Island till April 1st
Gwenn told me to put everything into RLMD...she was ‘Yar’
My morning e mail:
I still recommend RLMD here but certainly if it ever drops below 25. It seems to sell off in the mornings then strengthens in early afternoon, seems to be trying to get back above $30 now.
I don’t know of any developments lately, positive or negative, I assume the first buy recommendation is being written about it by one of 3 brokerage firms that know about RLMD. Nobody else seems to know about it still.
Another positive event would be having the FDA designate their drug REL-1017 a ‘breakthrough therapy’ they are already on the FDA list of Fast Track approval candidates, back in 2017, ‘Breakthrough’ designation brings additional support from the FDA.
I think in a year it will be over $100/ share and much higher in 3 years if it isn’t acquired. To their credit there are no huge egos involved, they want to bring this drug to market as soon as possible, they don’t seem to be interested in building a corporate monument.
This is the announcement that drove the stock from 11 to 36 in one day, cooled off after that but seems to be climbing back up:
https://www.relmada.com/news-events/press-releases/detail/200/relmada-therapeutics-announces-top-line-results-from
I post my ramblings on this message board “IHUB” under the name ‘VictorMasonIsRight’ ( my nick name at Lehman Brothers, they didn’t think my name was cool enough):
https://investorshub.advfn.com/Relmada-Therapeutics-Inc-RLMD-28735/
The company does not leak inside information so everything I say is my own opinion. Feel free to send this to any trusted advisor or friend. I will send you more info soon. I also write about it on twitter as ‘@XXXXXXXXXXX68’
Padre Island till April 1st
Gwenn told me to put everything into RLMD...she was ‘Yar’
Recent RLMD News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 08:31:38 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/17/2026 08:30:44 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/10/2026 04:15:17 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/09/2026 08:20:40 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/06/2026 08:35:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/03/2026 08:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:52:59 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:25:32 PM
- Relmada Therapeutics shares jump 25% after promising bladder cancer trial results • IH Market News • 03/09/2026 01:51:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:11:01 AM
- Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (Canada) • 02/26/2026 05:07:00 PM
- Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (US) • 02/26/2026 05:07:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 02:15:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2026 10:14:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:30:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:29:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:28:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 12:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:58:16 PM
